|Articles|March 1, 2001
- Pharmaceutical Executive-03-01-2001
- Volume 0
- Issue 0
Privacy, Pediatrics, and Policy
FDA proposals for expanding the pediatric study program include tax incentives and }transferable exclusivity.}
Advertisement
Articles in this issue
over 25 years ago
Research: New Horizonsover 25 years ago
Earnings: Tough Times Aheadover 25 years ago
Outbreak: Anthrax Alarmover 25 years ago
Patents: China on the Genome Mapover 25 years ago
Lilly's International Familyover 25 years ago
Update: Punishment and Reprieveover 25 years ago
Shortage: Vaccine Worriesover 25 years ago
Gateway to Japanover 25 years ago
SurroundedAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results
2
Novavax's Strategy Across Commercial, R&D, and Partnerships
3
Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson
4
FDA Approves Skinvive by Juvéderm for Improvement of Neck Appearance
5